Our study shows that among women with early-onset breast cancer (≤35 years old) and with a family history of breast cancer, a higher prevalence of BRCA1 mutations is present in women with TNBC compared with women with non-TNBC. The gene discussed is BRCA1; the disease is breast cancer.